Association of response to programmed death receptor 1 (PD-1) blockade with pembrolizumab (MK-3475) with an interferon-inflammatory immune gene signature.Antoni Ribas, Adil Daud, Anthony M. Joshua et al.|Journal of Clinical Oncology|2015Cited by 200
Relationship between immune gene signatures and clinical response to PD-1 blockade with pembrolizumab (MK-3475) in patients with advanced solid tumorsMark Ayers, Terri McClanahan, Jared Lunceford et al.|Journal for ImmunoTherapy of Cancer|2015Cited by 41